Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

230 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Disease-free Survival and Local Recurrence After Laparoscopic-assisted Resection or Open Resection for Rectal Cancer: The Australasian Laparoscopic Cancer of the Rectum Randomized Clinical Trial.
Stevenson ARL, Solomon MJ, Brown CSB, Lumley JW, Hewett P, Clouston AD, Gebski VJ, Wilson K, Hague W, Simes J; Australasian Gastro-Intestinal Trials Group (AGITG) ALaCaRT investigators. Stevenson ARL, et al. Among authors: simes j. Ann Surg. 2019 Apr;269(4):596-602. doi: 10.1097/SLA.0000000000003021. Ann Surg. 2019. PMID: 30247332 Clinical Trial.
Functional Outcome of Laparoscopic-Assisted Resection Versus Open Resection of Rectal Cancer: A Secondary Analysis of the Australasian Laparoscopic Cancer of the Rectum Trial.
Keane CR, O'Grady G, Bissett IP, Hayes JL, Hulme-Moir M, Eglinton TW, Solomon MJ, Lumley JW, Simes J, Stevenson ARL. Keane CR, et al. Among authors: simes j. Dis Colon Rectum. 2022 Jul 1;65(7):e698-e706. doi: 10.1097/DCR.0000000000002166. Epub 2022 Nov 11. Dis Colon Rectum. 2022. PMID: 34775413 Clinical Trial.
Patient-Reported Bowel, Urinary, and Sexual Outcomes After Laparoscopic-Assisted Resection or Open Resection for Rectal Cancer: The Australasian Laparoscopic Cancer of the Rectum Randomized Clinical Trial (ALaCart).
Mercieca-Bebber R, Eggins R, Brown K, Gebski VJ, Brewer K, Lai L, Bailey L, Solomon MJ, Lumley JW, Hewett P, Clouston AD, Wilson K, Hague W, Hayes J, White S, Morgan M, Simes RJ, Stevenson ARL. Mercieca-Bebber R, et al. Among authors: simes rj. Ann Surg. 2023 Mar 1;277(3):449-455. doi: 10.1097/SLA.0000000000005412. Epub 2022 Feb 15. Ann Surg. 2023. PMID: 35166265 Clinical Trial.
Sentinel-Lymph-Node-Based Management or Routine Axillary Clearance? Five-Year Outcomes of the RACS Sentinel Node Biopsy Versus Axillary Clearance (SNAC) 1 Trial: Assessment and Incidence of True Lymphedema.
Wetzig N, Gill PG, Espinoza D, Mister R, Stockler MR, Gebski VJ, Ung OA, Campbell I, Simes J. Wetzig N, et al. Among authors: simes j. Ann Surg Oncol. 2017 Apr;24(4):1064-1070. doi: 10.1245/s10434-016-5669-2. Epub 2016 Nov 15. Ann Surg Oncol. 2017. PMID: 27848050 Clinical Trial.
AGITG MASTERPLAN: a randomised phase II study of modified FOLFIRINOX alone or in combination with stereotactic body radiotherapy for patients with high-risk and locally advanced pancreatic cancer.
Oar A, Lee M, Le H, Wilson K, Aiken C, Chantrill L, Simes J, Nguyen N, Barbour A, Samra J, Sjoquist KM, Moore A, Espinoza D, Gebski V, Yip S, Chu J, Kneebone A, Goldstein D. Oar A, et al. Among authors: simes j. BMC Cancer. 2021 Aug 19;21(1):936. doi: 10.1186/s12885-021-08666-y. BMC Cancer. 2021. PMID: 34412605 Free PMC article.
Identification of the sentinel lymph node in the SNAC-1 trial.
Elmadahm AA, Gill PG, Bochner M, Gebski VJ, Zannino D, Wetzig N, Campbell I, Stockler M, Ung O, Simes J, Uren R. Elmadahm AA, et al. Among authors: simes j. ANZ J Surg. 2015 Jan;85(1-2):58-63. doi: 10.1111/ans.12527. Epub 2014 Feb 15. ANZ J Surg. 2015. PMID: 25626066 Clinical Trial.
TOPGEAR: a randomised phase III trial of perioperative ECF chemotherapy versus preoperative chemoradiation plus perioperative ECF chemotherapy for resectable gastric cancer (an international, intergroup trial of the AGITG/TROG/EORTC/NCIC CTG).
Leong T, Smithers BM, Michael M, Gebski V, Boussioutas A, Miller D, Simes J, Zalcberg J, Haustermans K, Lordick F, Schuhmacher C, Swallow C, Darling G, Wong R. Leong T, et al. Among authors: simes j. BMC Cancer. 2015 Jul 21;15:532. doi: 10.1186/s12885-015-1529-x. BMC Cancer. 2015. PMID: 26194186 Free PMC article. Clinical Trial.
VEGF-A, VEGFR1 and VEGFR2 single nucleotide polymorphisms and outcomes from the AGITG MAX trial of capecitabine, bevacizumab and mitomycin C in metastatic colorectal cancer.
Chionh F, Gebski V, Al-Obaidi SJ, Mooi JK, Bruhn MA, Lee CK, Chüeh AC, Williams DS, Weickhardt AJ, Wilson K, Scott AM, Simes J, Hardingham JE, Price TJ, Mariadason JM, Tebbutt NC. Chionh F, et al. Among authors: simes j. Sci Rep. 2022 Jan 24;12(1):1238. doi: 10.1038/s41598-021-03952-y. Sci Rep. 2022. PMID: 35075138 Free PMC article. Clinical Trial.
230 results